Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Spotlight: October 2024
Catch up on all the biggest news to hit the pharmaceutical industry last month, spanning from new acquisitions, approvals, insights on the NHS and more.
Sustainable pharma packaging takes a big step forward
UPM Biochemicals, Selenis and Bormioli Pharma have introduced the pharmaceutical industry’s first bottle made with wood-based PET.
Spoonful of Technology: Sept-Oct
Take a look at the latest examples of how pharma and its partners are working together to develop technology to solve key challenges.
ABPI welcomes the UK Chancellor’s new Budget
The Association of the British Pharmaceutical Industry has expressed support for the first Labour budget in 14 years.
How HCPs consumed medical content in 2024
This infographic explores how healthcare professionals engaged with medical content in 2024, highlighting their HCP content preferences and more.
CDC panel backs expanded use of pneumococcal vaccines in adults
Pfizer and Merck’s pneumococcal vaccines have been recommended for adults aged 50 and over in the US, potentially opening up a new market.
How to maximise your year-end medical affairs and marketing budget
In the final quarter of the year, how can pharmaceutical teams make their final budget decisions count?
Merck acquires Modifi Biosciences in $1.3bn cancer therapy deal
The acquisition strengthens Merck’s oncology portfolio as the company looks to off the expiration of the patent for pembrolizumab.
ARS' Richard Lowenthal on his mission to transform allergy care
Richard Lowenthal, CEO, ARS Pharmaceuticals, reveals the company’s mission to address unmet needs in allergy care with its new nasal spray.
HCPs rank pharma in top sectors for trust, says Ipsos
Healthcare professionals’ trust in the pharmaceutical industry has risen since 2020, with many doctors and nurses now expressing high trust.
←
1
2
3
…
6
7
8
9
10
11
12
…
27
28
29
→
We’ve noticed you’re accessing
from
North/South America.
View
View